Paraskevi Giannakakou
Affiliations: | Weill Cornell Medical College, New York, NY, United States |
Area:
Oncology, Cell Biology, PharmacologyGoogle:
"Paraskevi Giannakakou"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Mukhtar E, Worroll D, Galletti G, et al. (2020) Quantitative analysis of taxane drug target engagement of microtubules in circulating tumor cells from metastatic castration resistant prostate cancer patients treated with CRXL301, a nanoparticle of docetaxel. Cancer Drug Resistance (Alhambra, Calif.). 3: 636-646 |
| Shah MA, Enzinger P, Ko AH, et al. (2020) Multicenter phase II study of Cabazitaxel in advanced gastroesophageal cancer: Association of HER2 Expression and M2-like Tumor Associated Macrophages with Patient Outcome. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Gjyrezi A, Xie F, Voznesensky O, et al. (2020) Taxane resistance in prostate cancer is mediated by decreased drug-target engagement. The Journal of Clinical Investigation. 130: 3287-3298 |
| Galletti G, Zhang C, Gjyrezi A, et al. (2020) Microtubule engagement with taxane is altered in taxane-resistant gastric cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Brown LC, Halabi S, Schonhoft J, et al. (2020) Association of circulating tumor cell chromosomal instability with worse outcomes in men with mCRPC treated with abiraterone or enzalutamide. Journal of Clinical Oncology. 38: 183-183 |
| Gupta S, Halabi S, Kemeny G, et al. (2020) Circulating tumor cell (CTC) genomic signatures of hormone therapy resistance in men with metastatic castration-resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 38: 147-147 |
| Mukhtar E, Worroll D, Galletti G, et al. (2020) Abstract 3196: Analysis of taxane drug target engagement of microtubules in circulating tumor cells from metastatic castration resistant prostate cancer patients treated with CRLX301, a nanoparticle of docetaxel Clinical Trials |
| Sarkar S, Thakkar PK, Lenz H, et al. (2020) Abstract 2011: HER2 expression and M2-like tumor infiltrating macrophages associated with Cabazitaxel activity in gastric cancer Clinical Trials |
| Madhukar NS, Khade PK, Huang L, et al. (2019) A Bayesian machine learning approach for drug target identification using diverse data types. Nature Communications. 10: 5221 |
| Tagawa ST, Antonarakis ES, Gjyrezi A, et al. (2019) Clinical Significance of AR-V567es in Prostate Cancer-Response. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 25: 6010-6011 |